Patents by Inventor Anthony B. Reed

Anthony B. Reed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE
    Publication number: 20110224248
    Abstract: Compounds of Formula I are useful inhibitors of HIF prolyl hydroxylases. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.
    Type: Application
    Filed: May 17, 2011
    Publication date: September 15, 2011
    Applicant: Amgen Inc.
    Inventors: Jennifer R. Allen, Roland Burli, Marian C. Bryan, Guo-Qiang Cao, Susana C. Neira, Anthony B. Reed
  • S1P1 receptor agonists and use thereof
    Patent number: 7842685
    Abstract: The present invention relates to compounds of Formula (I): that are have activity as S1P receptor modulating agents, more specifically to specifically compounds that are S1P1 receptor agonists. The invention also related to the use of such compounds to treat diseases associated with inappropriate S1P1 receptor activity such as autoimmune diseases.
    Type: Grant
    Filed: June 18, 2009
    Date of Patent: November 30, 2010
    Assignee: Amgen Inc.
    Inventors: Victor J. Cee, Michael J. Frohn, Brian Alan Lanman, Susana C. Neira, Anthony B. Reed, Kelvin K. C. Sham
  • INHIBITORS OF PI3 KINASE AND/OR MTOR
    Publication number: 20100273764
    Abstract: The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein the variables are as defined herein.
    Type: Application
    Filed: April 27, 2010
    Publication date: October 28, 2010
    Applicant: Amgen Inc.
    Inventors: Kristin Andrews, Yunxin Y. Bo, Shon Booker, Victor J. Cee, Noel D'Angelo, Bradley J. Herberich, Fang-Tsao Hong, Claire L.M. Jackson, Brian A. Lanman, Hongyu Liao, Longbin Liu, Nobuko Nishimura, Mark H. Norman, Liping H. Pettus, Anthony B. Reed, Adrian L. Smith, Seifu Tadesse, Nuria A. Tamayo, Bin Wu, Ryan Wurz, Kevin Yang
  • S1P1 receptor agonists and use thereof
    Publication number: 20100029611
    Abstract: The present invention relates to compounds of Formula (I): that are have activity as S1P receptor modulating agents, more specifically to specifically compounds that are S1P1 receptor agonists. The invention also related to the use of such compounds to treat diseases associated with inappropriate S1P1 receptor activity such as autoimmune diseases.
    Type: Application
    Filed: June 18, 2009
    Publication date: February 4, 2010
    Applicant: Amgen Inc.
    Inventors: Victor J. Cee, Michael J. Frohn, Brian Alan Lanman, Susana C. Neira, Anthony B. Reed, Kelvin K.C. Sham
  • Indanone derivatives that inhibit prolyl hydroxylase
    Patent number: 7569726
    Abstract: Compounds of Formula I are useful inhibitors of HIF prolyl hydroxylases. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.
    Type: Grant
    Filed: April 9, 2008
    Date of Patent: August 4, 2009
    Assignee: Amgen Inc.
    Inventors: Jennifer R. Allen, Roland Burli, Jennifer E. Golden, Kristine M. Muller, Anthony B. Reed
  • Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity
    Publication number: 20090156633
    Abstract: Compounds of Formula I are useful inhibitors of HIF prolyl hydroxylases. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.
    Type: Application
    Filed: April 29, 2008
    Publication date: June 18, 2009
    Applicant: Amgen Inc.
    Inventors: Jennifer R. Allen, Roland Burli, Michael J. Frohn, Randall W. Hungate, Susana C. Neira, Anthony B. Reed
  • Quinolones and azaquinolones that inhbit prolyl hydroxylase
    Publication number: 20090156605
    Abstract: Compounds of Formula I are useful inhibitors of HIF prolyl hydroxylases. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.
    Type: Application
    Filed: April 16, 2008
    Publication date: June 18, 2009
    Applicant: Amgen Inc.
    Inventors: Jennifer R. Allen, Roland Burli, Marian C. Bryan, Guo-Qiang Cao, Susana C. Neira, Anthony B. Reed
  • Indanone derivatives that inhibit prolyl hydroxylase
    Publication number: 20090088475
    Abstract: Compounds of Formula I are useful inhibitors of HIF prolyl hydroxylases. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.
    Type: Application
    Filed: April 9, 2008
    Publication date: April 2, 2009
    Applicant: Amgen Inc.
    Inventors: Jennifer R. Allen, Roland Burli, Jennifer E. Golden, Kristine M. Muller, Anthony B. Reed